Taking stock: AmSurg's upside, Barron's on Clarcor

Analysts at Goldman Sachs have relaunched coverage of AmSurg Corp. with a 'buy' rating and a price target of $101. That leaves almost 20 percent of upside from where the Nashville-based ambulatory surgery and physician services company (Ticker: AMSG) was trading in early Monday action.

Shares of Clarcor (Ticker: CLC) were up about 1 percent to $53.15 Monday morning after Barron's this weekend said the stock could rise 20 percent or more from its current beaten-up state. While acknowledging that demand is likely to remain weak through 2016, David Englander says "a focused strategy on growing the filter business and cutting costs could help drive up earnings and free cash flow, even on flattish revenue."

Nov 30, 2015 12:48 PM

Analysts cut rating, target for Cracker Barrel

Argus Research analyst John Staszak has downgraded shares of Cracker Barrel Old Country after the Lebanon-based restaurant and retail company reported solid fiscal first-quarter profits but said its traffic trends will remain soft for a while. Staszak now rates Cracker Barrel, which closed last Wednesday (Ticker: CBRL) above $130, at 'hold' and says he sees "little room for P/E multiple expansion in the near term."

Separately, veteran local restaurant analyst Bob Derrington — who this summer moved to Telsey Advisory Group — has trimmed his price target for Cracker Barrel to $142 from $155 on the back of the Q1 results. Derrington in late October had lowered his target from $165.

Nov 30, 2015 6:53 AM

BB&T raises rating on Dollar General

BB&T Capital Market analyst Anthony Chukumba has raised his rating on shares of Dollar General to 'buy' from 'hold.' The move came after the stock (Ticker: DG) slid nearly 10 percent in the past month to the low $60s. Chukumba sees it climbing to $78.

Nov 23, 2015 8:44 AM

Avondale: AAC at 'compelling valuation'

Avondale Partners analyst Paula Torch says investors should look at the beaten-up shares of AAC Holdings — they've recovered only slightly from their summer slump — as a chance to buy a company with a clear growth pipeline and the financing to pull it off.

Yes, the legal issues in California that caused the stock to fall in the summer are still there, Torch says, but she has her fingers crossed that there will be clarity in the coming months. In the meantime, the AAC team has access to $100 million in M&A capital, and an organic expansion push should grow to 1,200 the beds in AAC's portfolio next year, with another 150 new beds slated for 2017.

"AAC continues to execute well and fundamentals remain intact with overhangs resulting in a compelling valuation vs. growth. We believe census remains strong, referral sources are healthy, and recent financing provides an extended bridge to execute on its current expansion plans," said Torch, who is sticking by her $32 price target for AAC, shares of which are changing hands this morning at $22.70.

Nov 20, 2015 8:59 AM

Why one analyst isn't concerned about Cat Financial

Investors are starting to ask serious questions about the companies lending money to the post-peak energy and agriculture sectors, so it's natural that Barclays analyst Robert Wertheimer and his peers are being asked about Caterpillar Financial in addition to the Deere and CNH Industrial. But Wertheimer isn't concerned about the portfolio of West End-based Cat Financial, which is having to swallow some bitter medicine as its parent company retrenches. The lender, Wertheimer says, is growing market share and should benefit from its greater exposure to the construction sector. Read more of his thoughts here.

Nov 18, 2015 6:58 AM

Wolfe lowers Dollar General to 'market perform'

Scott Mushkin at Wolfe Research his trimmed his rating on shares of Dollar General to 'market perform' from 'outperform.' The move comes after a month in which the leaders of the Goodlettsville-based retailer announced big job cuts at headquarters and in which the stock was pulled down by a sales warning from Walmart. Shares of Dollar General (Ticker: DG) are changing hands this afternoon at $65.87, down almost 2 percent on the day. Year to date, they're down 7 percent.

Nov 10, 2015 2:07 PM

Stifel cuts Healthcare Realty rating

Shares of Healthcare Realty Trust are down more than 2 percent Friday (Ticker: HR) following a move by analysts at Stifel Nicolaus to downgrade the company to 'hold' from 'buy.' The retreat has taken the stock back to where it was five weeks ago. Year to date, Healthcare Realty is off about 7 percent.

Nov 6, 2015 1:39 PM

Analyst action: LP, LifePoint

RBC Capital Markets analyst Paul Quinn really likes the look at Louisiana-Pacific shares following the company's third-quarter earnings report. He has boosted his rating on the downtown-based company to 'top pick' status from 'outperform' and lifted his price target to $22 from $20, citing stronger pricing trends for its oriented strand board products and an upswing in its siding business. On Thursday afternoon, LP shares (Ticker: LPX) were trading up about 1 percent to $17.35.

A number of analysts have trimmed their price target for LifePoint Health shares in the wake of that company's Q3 report. BMO Capital Markets has taken its target to $74 from $81 while Leerink Partners has come down to $82 from $87 and RBC Capital Markets now sees the stock climbing to $96 instead of $107. LifePoint shares (Ticker: LPNT) have traded around $70 all week. Year to date, they're off slightly.

Nov 5, 2015 2:56 PM

Analyst action: Avondale, Mizuho on CHS

Avondale Partners analyst Paula Torch has lowered her price target for Community Health Systems from $60 to $40 based on the Franklin company's weak third quarter. However, Torch is maintaining her 'market outperform' rating for the company and says there is opportunity for CHS to improve during the fourth quarter because of the solid performance expected from its legacy facilities.

"Former HMA facilities continue to create a drag on earnings," Torch wrote in a report this week.

Additionally, Mizuho Securities analyst Sheryl Skolnick has cut her price target for the second time in two weeks, from $34 to $30. In late October, she slashed her target from $77 after CHS issued a profit warning.

Shares of CHS (Ticker: CYH) were up 3.5 percent mid-day Wednesday to $28.34. Year to date, though they're still down 47 percent.

Nov 4, 2015 11:31 AM

Analysts trim Healthways targets

Barrington Research analyst Michael Petusky has trimmed his price target for shares of Healthways to $13 from $18 following the population health services company’s quarterly report and the unveiling of a wide-ranging restructuring plan. Petusky still has Healthways at ‘outperform.’

Over at Barclays, Josh Raskin is still a little more guarded at ‘underweight.’ He also has cut his target for Healthways shares (Ticker: HWAY), which closed Tuesday at $11.48, to $12 from $15.

Nov 4, 2015 7:20 AM